Global Antiandrogen Monotherapy Market Research Report Forecast 2017-2022

July 2017 | 106 pages | ID: G4C90D8B6A4EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global Antiandrogen Monotherapy Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Antiandrogen Monotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antiandrogen Monotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Antiandrogen Monotherapy Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Global Antiandrogen Monotherapy Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

Global Antiandrogen Monotherapy Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Antiandrogen Monotherapy Market Segmentation by Type
  1.2.1 Global Production Market Share of Antiandrogen Monotherapy by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Antiandrogen Monotherapy Market Segmentation by Application
  1.3.1 Antiandrogen Monotherapy Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Antiandrogen Monotherapy Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Antiandrogen Monotherapy (2012-2022)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON ANTIANDROGEN MONOTHERAPY INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET COMPETITION BY MANUFACTURERS

3.1 Global Antiandrogen Monotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 Global Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Antiandrogen Monotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
  3.5.1 Antiandrogen Monotherapy Market Concentration Rate
  3.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Antiandrogen Monotherapy Production by Region (2012-2017)
4.2 Global Antiandrogen Monotherapy Production Market Share by Region (2012-2017)
4.3 Global Antiandrogen Monotherapy Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL ANTIANDROGEN MONOTHERAPY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Antiandrogen Monotherapy Consumption by Regions (2012-2017)
5.2 North America Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Antiandrogen Monotherapy Production and Market Share by Type (2012-2017)
6.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
6.3 Global Antiandrogen Monotherapy Price by Type (2012-2017)
6.4 Global Antiandrogen Monotherapy Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION

7.1 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2012-2017)
7.2 Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS

8.1 Pfizer Inc. (USA)
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Abbott Laboratories (USA)
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Genentech Inc. (USA)
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 GlaxoSmithKline Plc (UK)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Immunomedics, Inc. (USA)
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Indevus Pharmaceuticals Inc. (USA)
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Novartis AG (Switzerland)
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 OSI Pharmaceuticals, Inc. (USA)
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Paladin Labs Inc. (Canada)
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS

9.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Antiandrogen Monotherapy Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2017-2022)

13.1 Global Antiandrogen Monotherapy Production, Revenue Forecast (2017-2022)
13.2 Global Antiandrogen Monotherapy Production, Consumption Forecast by Regions (2017-2022)
13.3 Global Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
13.4 Global Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)
13.5 Antiandrogen Monotherapy Price Forecast (2017-2022)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen Monotherapy
Figure Global Production Market Share of Antiandrogen Monotherapy by Type in 2016
Table Antiandrogen Monotherapy Consumption Market Share by Application in 2016
Figure North America Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Antiandrogen Monotherapy Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Antiandrogen Monotherapy Capacity of Key Manufacturers (2015 and 2016)
Table Global Antiandrogen Monotherapy Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Antiandrogen Monotherapy Capacity of Key Manufacturers in 2015
Figure Global Antiandrogen Monotherapy Capacity of Key Manufacturers in 2016
Table Global Antiandrogen Monotherapy Production of Key Manufacturers (2015 and 2016)
Table Global Antiandrogen Monotherapy Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Production Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Production Share by Manufacturers
Table Global Antiandrogen Monotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table Global Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2016
Table Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Antiandrogen Monotherapy Product Type
Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers
Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers
Table Global Antiandrogen Monotherapy Capacity by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Capacity Market Share by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Antiandrogen Monotherapy Capacity Market Share by Regions
Table Global Antiandrogen Monotherapy Production by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Production and Market Share by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Production Market Share by Regions (2012-2017)
Figure 2015 Global Antiandrogen Monotherapy Production Market Share by Regions
Table Global Antiandrogen Monotherapy Revenue by Regions (2012-2017)
Table Global Antiandrogen Monotherapy Revenue Market Share by Regions (2012-2017)
Table 2015 Global Antiandrogen Monotherapy Revenue Market Share by Regions
Table Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Antiandrogen Monotherapy Consumption Market by Regions (2012-2017)
Table Global Antiandrogen Monotherapy Consumption Market Share by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Antiandrogen Monotherapy Consumption Market Share by Regions
Table North America Antiandrogen Monotherapy Production, Consumption, Import & Export (2012-2017)
Table Europe Antiandrogen Monotherapy Production, Consumption, Import & Export (2012-2017)
Table China Antiandrogen Monotherapy Production, Consumption, Import & Export (2012-2017)
Table Japan Antiandrogen Monotherapy Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Antiandrogen Monotherapy Production, Consumption, Import & Export (2012-2017)
Table India Antiandrogen Monotherapy Production, Consumption, Import & Export (2012-2017)
Table Global Antiandrogen Monotherapy Production by Type (2012-2017)
Table Global Antiandrogen Monotherapy Production Share by Type (2012-2017)
Figure Production Market Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure 2015 Production Market Share of Antiandrogen Monotherapy by Type
Table Global Antiandrogen Monotherapy Revenue by Type (2012-2017)
Table Global Antiandrogen Monotherapy Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure 2015 Revenue Market Share of Antiandrogen Monotherapy by Type
Table Global Antiandrogen Monotherapy Price by Type (2012-2017)
Figure Global Antiandrogen Monotherapy Production Growth by Type (2012-2017)
Table Global Antiandrogen Monotherapy Consumption by Application (2012-2017)
Table Global Antiandrogen Monotherapy Consumption Market Share by Application (2012-2017)
Figure Global Antiandrogen Monotherapy Consumption Market Share by Application in 2015
Table Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
Figure Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure Global Antiandrogen Monotherapy Production and Growth Rate Forecast (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Table Global Antiandrogen Monotherapy Production Forecast by Regions (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Forecast by Regions (2017-2022)
Table Global Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)